{"id":1418,"date":"2018-05-24T14:54:19","date_gmt":"2018-05-24T13:54:19","guid":{"rendered":"http:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png"},"modified":"2018-05-24T14:54:19","modified_gmt":"2018-05-24T13:54:19","slug":"01-2018-abstract-asco-gi-a-phase-i-ii-trial-of-nbtxr3-in-the-treatment-of-liver-cancer-2","status":"inherit","type":"attachment","link":"https:\/\/bibliography.nanobiotix.com\/fr\/2018-asco-gi-a-phase-i-ii-trial-of-nbtxr3-nanoparticles-activated-by-sbrt-in-the-treatment-of-liver-cancers\/01-2018-abstract-asco-gi-a-phase-i-ii-trial-of-nbtxr3-in-the-treatment-of-liver-cancer-2\/","title":{"rendered":"01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer"},"author":1,"comment_status":"open","ping_status":"closed","template":"","meta":[],"aioseo_notices":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png'><img width=\"212\" height=\"300\" src=\"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-212x300.png\" class=\"attachment-medium size-medium\" alt=\"\" decoding=\"async\" loading=\"lazy\" srcset=\"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-212x300.png 212w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-768x1086.png 768w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-724x1024.png 724w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png 800w\" sizes=\"(max-width: 212px) 100vw, 212px\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"image","mime_type":"image\/png","media_details":{"width":800,"height":1131,"file":"2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png","sizes":{"thumbnail":{"file":"01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-150x150.png","width":150,"height":150,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-150x150.png"},"medium":{"file":"01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-212x300.png","width":212,"height":300,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-212x300.png"},"medium_large":{"file":"01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-768x1086.png","width":768,"height":1086,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-768x1086.png"},"large":{"file":"01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-724x1024.png","width":724,"height":1024,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer-724x1024.png"},"full":{"file":"01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png","width":800,"height":1131,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]}},"post":1427,"source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2018\/05\/01-2018-abstract-ASCO-GI-a-phase-I-II-trial-of-NBTXR3-in-the-treatment-of-liver-cancer.png","_links":{"self":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media\/1418"}],"collection":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/comments?post=1418"}]}}